These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9553985)
1. Lack of correlation between soluble CD14 and IL-6 in meningococcal septic shock. Arranz E; Blanco-Quirós A; Solís P; Garrote JA Pediatr Allergy Immunol; 1997 Nov; 8(4):194-9. PubMed ID: 9553985 [TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775 [TBL] [Abstract][Full Text] [Related]
3. Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock. Pathan N; Williams EJ; Oragui EE; Stephens AC; Levin M Crit Care Med; 2005 Aug; 33(8):1839-44. PubMed ID: 16096463 [TBL] [Abstract][Full Text] [Related]
4. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S J Infect Dis; 1995 Jan; 171(1):229-32. PubMed ID: 7798670 [TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease. van Woensel JB; Biezeveld MH; Alders AM; Eerenberg AJ; Endert E; Hack EC; von Rosenstiel IA; Kuijpers TW J Infect Dis; 2001 Dec; 184(12):1532-7. PubMed ID: 11740728 [TBL] [Abstract][Full Text] [Related]
7. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock. Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104 [TBL] [Abstract][Full Text] [Related]
8. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034 [TBL] [Abstract][Full Text] [Related]
9. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease. Sprong T; van der Ven-Jongekrijg J; Neeleman C; van der Meer JW; van Deuren M Crit Care Med; 2009 Oct; 37(10):2812-8. PubMed ID: 19707127 [TBL] [Abstract][Full Text] [Related]
10. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma. Waage A; Aasen AO Immunol Rev; 1992 Jun; 127():221-30. PubMed ID: 1506005 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and its soluble receptor during acute meningococcal infections: effect of plasma or whole blood exchange. Frieling JT; van Deuren M; Wijdenes J; van Dalen R; Bartelink AK; van der Linden CJ; Sauerwein RW Crit Care Med; 1996 Nov; 24(11):1801-5. PubMed ID: 8917028 [TBL] [Abstract][Full Text] [Related]
12. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. Brandtzaeg P; Høgåsen K; Kierulf P; Mollnes TE J Infect Dis; 1996 Mar; 173(3):647-55. PubMed ID: 8627028 [TBL] [Abstract][Full Text] [Related]
13. Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock. Krafte-Jacobs B; Bock GH Crit Care Med; 1996 Sep; 24(9):1455-9. PubMed ID: 8797615 [TBL] [Abstract][Full Text] [Related]
14. Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia. Roldán V; Marín F; Blann A Blood Coagul Fibrinolysis; 2004 Mar; 15(2):179-82. PubMed ID: 15091005 [TBL] [Abstract][Full Text] [Related]
15. Complement activation in relation to capillary leakage in children with septic shock and purpura. Hazelzet JA; de Groot R; van Mierlo G; Joosten KF; van der Voort E; Eerenberg A; Suur MH; Hop WC; Hack CE Infect Immun; 1998 Nov; 66(11):5350-6. PubMed ID: 9784543 [TBL] [Abstract][Full Text] [Related]
16. Increment of plasma soluble CD14 level in carrageenan-primed endotoxin shock model mice. Hozumi H; Adachi Y; Murakami T; Miura NN; Ohno N Biol Pharm Bull; 2006 May; 29(5):1015-21. PubMed ID: 16651737 [TBL] [Abstract][Full Text] [Related]
17. Function of soluble CD14 in serum from patients with septic shock. Landmann R; Reber AM; Sansano S; Zimmerli W J Infect Dis; 1996 Mar; 173(3):661-8. PubMed ID: 8627030 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Blanco A; Solis G; Arranz E; Coto GD; Ramos A; Telleria J Acta Paediatr; 1996 Jun; 85(6):728-32. PubMed ID: 8816213 [TBL] [Abstract][Full Text] [Related]
19. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456 [TBL] [Abstract][Full Text] [Related]
20. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. den Brinker M; Joosten KF; Liem O; de Jong FH; Hop WC; Hazelzet JA; van Dijk M; Hokken-Koelega AC J Clin Endocrinol Metab; 2005 Sep; 90(9):5110-7. PubMed ID: 15985474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]